Water-dispersible PEG-curcumin/amine-functionalized covalent organic framework nanocomposites as smart carriers for in vivo drug delivery.
Zhang G, Li X, Liao Q, Liu Y, Xi K, Huang W, Jia X. · 2018
Read Water-dispersible PEG-curcumin/amine-functionalized covalent organic framework nanocomposites as smart carriers for in vivo drug delivery. by Zhang G, Li X, Liao Q, Liu Y, Xi K, Huang W, Jia X. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6050241.txt.
Introduction
Zhang and co-authors build a water-friendly carrier for cancer drugs. Their research article appeared in Nature Communications. The carrier joins a covalent organic framework with a curcumin-based polymer coat. Such frameworks are porous crystals built only from organic parts. Poor stability in body fluids had kept them out of in vivo studies.
The coat lets the particles disperse in water and glow. That glow lets the team track uptake and drug release inside cells. The carrier loaded the drug doxorubicin at high levels. It circulated longer and gathered more drug in tumors. One version also reached the brain well. Readers get a platform aimed at targeted drug delivery in living animals.
Catalog record
| CREATOR | Zhang G, Li X, Liao Q, Liu Y, Xi K, Huang W, Jia X. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Water-dispersible PEG-curcumin/amine-functionalized covalent organic framework nanocomposites as smart carriers for in vivo drug delivery By Guiyang Zhang, Xinle Li, Qiaobo Liao, Yanfeng Liu, Kai Xi, Wenyu Huang, Xudong Jia Published in: Nature Communications DOI: 10.1038/s41467-018-04910-5 ABSTRACT Covalent organic frameworks (COFs) as drug-delivery carriers have been mostly evaluated in vitro due to the lack of COFs nanocarriers that are suitable for in vivo studies. Here we develop a series of water-dispersible polymer-COF nanocomposites through the assembly of polyethylene-glycol-modified monofunctional curcumin derivatives (PEG-CCM) and amine-functionalized COFs (APTES-COF-1) for in vitro and in vivo drug delivery. The real-time fluorescence response shows efficient tracking of the COF-based materials upon cellular uptake and anticancer drug (doxorubicin (DOX)) release. Notably, in vitro and in vivo studies demonstrate that PEG-CCM@APTES-COF-1 is a smart carrier for drug delivery with superior stability, intrinsic biodegradability, high DOX loading capacity, strong and stable fluorescence, prolonged circulation time and improved drug accumulation in tumors. More intriguingly, PEG350-CCM@APTES-COF-1 presents an effective targeting strategy for brain research. We envisage that PEG-CCM@APTES-COF-1 nanocomposites represent a great promise toward the development of a multifunctional platform for cancer-targeted in vivo drug delivery. INTRODUCTION Covalent organic frameworks (COFs) have garnered considerable interest due to their widespread applications in gas storage1–3, optoelectronic and electrical energy storage devices4–6, nanochannels7,8, catalysis9–14, temperature sensing15, and photovoltaics16. Considering that COFs are solely constructed with organic building blocks17–21, exploring their potential in the biomedical field is obvious due to their inherent advantages, such as large surface area, enormous porosity, biocompatibility, and tunable functionality. Recent studies have demonstrated that COFs can serve as drug-delivery carriers with high loading capacity and efficient drug-release behavior22,23. However, the intrinsic limitations of COF materials, including their poor physiological stability, nonspecific targeting, and low cell-membrane permeability, severely restrain their practical implementation, and research on COFs in drug delivery remains in its infancy. Despite pioneering studies uncovering the great potential of COFs in drug delivery22–25, further optimization in the following aspects must be considered for the design of optimal drug-delivery carriers for in vivo applications. (1) Optimal size: the optimal particle size for efficient cellular uptake is below 200 nm. However, the previously reported COF drug carriers possessed much larger sizes and poor dispersion. (2) Drug loading: plenty of reported loading methods have been based on equilibrium adsorption and diffusion26,27, which results in inconsistencies. (3) Good biocompatibility: cytotoxicity in biological systems must be minimized. (4) Controlled drug release: considering the limited number of release strategies employed in COFs materials, realizing a high targeting specificity and controlled drug release remains a challenge but is highly desirable. On the other hand, owing to the tunable properties of polymers, such as softness, thermal and chemical stability, and photoelectric properties, they have been widely integrated with porous materials to afford nanocomposites with desired properties28. Using polymers to modify COFs could be a promising method to adjust the stability, dispersity, and flexibility of these porous crystalline solids. The integration of polymers and porous materials has been reported in metal-organic frameworks (MOFs)/polymer composites29–31, which could be pre-prepared29,30 or post-prepared31 by the formation of MOF crystals using polymeric linkers or the attachment of polymer chains onto the functional ligand of MOF crystals. An amine-functionalized COF-1 has been reported by mixing 3-aminopropyl triethoxysilane (APTES) into established COF-1 recipe via Brønsted-type interactions25. In addition, monofunctional curcumin (CCM) derivatives modified by polyethylene glycol (PEG) hold three advantages: (a) the presence of free phenolic groups endows CCM with antioxidant biological activity32; (b) CCM could be used as a fluorescent label for tracking; and (c) using monofunctional derivatives to modify polymers could form soluble conjugates in high yields, while using bifunctional derivatives would result in cross-linked products with poor solubility33. Taking these factors into consideration, we anticipate that the COF-polymer hybridization could open up a new route for the design of multifunctional nanocomposites for efficient and controllable drug delivery. In this work, we develop a facile synthesis of a polymer-COF nanocomposite (denoted as PEG-CCM@APTES-COF-1) via the self-assembly of polyethylene-glycol-modified monofunctional curcumin derivatives (PEG-CCM) and amine-functionalized COF‑1 (APTES-COF-1). The entire structure of nanocomposites can be regarded as a micelle with APTES-COF-1 as the oil phase and PEG-CCM as the surfactant (Supplementary Figs 1 and 2). Inside the cell, PEG-CCM is unplugged, and doxorubicin (DOX) is released. Importantly, PEG-CCM@APTES-COF-1 shows strong fluorescence in both the solid state and solution, and the real-time fluorescence response is sufficient for tracking COF-based materials upon cellular uptake and DOX release. Fluorescence tracking experiments indicate that PEG-CCM@APTES-COF-1 efficiently accumulates in tumors after intravenous injection (Fig. 1). Meanwhile, using in vivo experiments, an enhanced tumor-inhibition effect is observed for the DOX-loaded PEG-CCM@APTES-COF-1 nanocarriers compared to the free DOX formulation. Thus, our study presents a facile approach for the synthesis of water-dispersible PEG-CCM@APTES-COF-1 nanocomposites as smart carriers for drug delivery with remarkable anticancer therapeutic efficiency. To the best of our knowledge, this represents a rare example that introduces the emerging research of polymer-COF assembly for therapeutic applications.Fig. 1Schematic representations. a–d Synthesis of DOX-loaded PEG-CCM@APTES-COF-1 with cellular uptake at weak acidic tumor tissue/cells (i.v. injection intravenous injection). e Synthesis of PEG-CCM amphiphilic block copolymers containing hydrophobic blocks based on the unplugging of the PEG-CCM polymer from the APTES-COF-1 pores RESULTS Characterization of the PEG-CCM@APTES-COF-1 nanocarriers The synthetic protocol of the PEG-CCM@APTES-COF-1 nanocomposites (denoted as CCM-COOH, PEG350-CCM, PEG1000-CCM, PEG2000-CCM, PEG350-CCM@APTES-COF-1, PEG1000-CCM@APTES-COF-1, and PEG2000-CCM@APTES-COF-1) is illustrated in Supplementary Fig. 1. The 1H nuclear magnetic resonance (NMR) spectra of the CCM-COOH, PEG350-CCM, PEG1000-CCM, and PEG2000-CCM derivatives (Supplementary Figs 3 and 4) showed three characteristic signals of CCM at 7.6, 6.5–7.2, and 5.35 ppm, assigned to the –CH=C (2H), Ar (6H), –OH (1H) protons, respectively. In addition, the series of PEG-CCM composites were characterized by electrospray ionization mass spectrometry (ESI-MS) and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). From the ESI-MS spectra (Supplementary Figs 5 and 6), the molecular weight evolution from PEG350-CCM to PEG1000-CCM is clearly observed. However, ESI-MS cannot precisely determine the molecular weight for samples with high molecular weights (>2000). Thus, a more accurate molecular weight of PEG2000-CCM was obtained by negative-mode MALDI-TOF MS (Supplementary Fig. 7), confirming that the product is mainly hydrophilic. PEG2000-CCM has a long PEG segment and a shorter CCM segment and thus is water soluble. The high-resolution transmission electron microscopy (HRTEM) image in Fig. 2a shows that there are many thin platelets with widths ranging from 120 to 150 nm, where the selected area electron diffraction (SAED) pattern indicates its retained crystallinity. To further functionalize the APTES-COF-1, a series of PEG polymers with various molecular weights were first introduced into the APTES-COF-1 vector via self-assembly. In addition to polymer encapsulation, surface modification of COFs with polymers is a fascinating approach to afford COF/polymer composites and imparts COFs with improved properties, such as hydrolytic stability and biocompatibility. Using this approach, a series of samples were prepared via the self-assembly of three PEG-modified CCM derivatives and APTES-COF-1. The monocarboxylic acid derivative of CCM was modified with a pendant carboxylic acid via standard coupling chemistry (Supplementary Fig. 1)34. To circumvent the intrinsic obstacles (e.g., low solubility35, rapid degradation34, low residence time, and fast release kinetics35–37), associated with CCM and improve its in vivo therapeutic efficacy, we utilized a covalent conjugation strategy to incorporate biodegradable linkages and thus obtained a series